taraxerol has been researched along with Innate Inflammatory Response in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhattacharjee, N; Dewanjee, S; Dua, TK; Kalita, J; Khanra, R; Manna, P; Nandy, A; Saha, A | 1 |
| Bhattacharjee, N; Dewanjee, S; Dua, TK; Khanra, R | 1 |
| Bai, Q; Li, G; Lü, C; Xu, H; Yao, X | 1 |
3 other study(ies) available for taraxerol and Innate Inflammatory Response
| Article | Year |
|---|---|
Taraxerol, a pentacyclic triterpenoid, from Abroma augusta leaf attenuates diabetic nephropathy in type 2 diabetic rats.
Topics: Animals; Computer Simulation; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Hyperglycemia; Inflammation; Malvaceae; Molecular Docking Simulation; Oleanolic Acid; Plant Leaves; Rats; Rats, Wistar; Streptozocin; Up-Regulation | 2017 |
Taraxerol, a pentacyclic triterpene from Abroma augusta leaf, attenuates acute inflammation via inhibition of NF-κB signaling.
Topics: Animals; Carrageenan; Cytokines; Edema; Inflammation; Inflammation Mediators; Malvaceae; NF-kappa B; Oleanolic Acid; Plant Leaves; Rats, Wistar; Signal Transduction; Triterpenes | 2017 |
Taraxerol inhibits LPS-induced inflammatory responses through suppression of TAK1 and Akt activation.
Topics: Active Transport, Cell Nucleus; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Line; Cyclooxygenase 2; Cytokines; Dinoprostone; Down-Regulation; Inflammation; Lipopolysaccharides; Macrophages; MAP Kinase Kinase Kinases; MAP Kinase Signaling System; Mice; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase; Oleanolic Acid; Oncogene Protein v-akt; RNA, Messenger | 2013 |